Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

计划入组 143 人 · 首次发布于 2021 年 2 月 24 日

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

计划入组 36 人 · 首次发布于 2022 年 4 月 12 日

NeuGene (calicivirus, AVI)

NeuGene (AVI BioPharma)

NeuGene (SARS, AVI)

Neuren Pharmaceuticals, Inc.

United States

Neuren Pharmaceuticals Ltd

Alkem Launches NeuCeno (cenobamate) in India, First Availability of the Anti-Seizure Drug for Partial-Onset Seizures

Neuren Pharmaceuticals Launches First-Ever Phase 3 Trial for Phelan-McDermid Syndrome

Imugene's Azer-Cel Trial Opens First Australian Site; Neuren's Daybue Sales Exceed Expectations